Possible Ameliorating Effect of N- Acetylcysteine (NAC) on Type-II Diabetes Induced Nephropathy
Status:
Active, not recruiting
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
The study is focused on the possible improving effect of N-acetylcysteine on nephropathy of
type-2 diabetic patients.
Study design: Prospective clinical based study. The aim of this work is to study the effect
of N-acetylcysteine (NAC) on proteinuria and on the serum level of lipoprotein a (LPa) in
diabetes induced nephropathy in type-2 diabetic patients.